Bankole Johnson, MD: Topiramate (Topamax) for alcohol dependency therapy
Dr. Bankole Johnson, Chair of Psychiatric Medicine at the University of Virginia and addiction therapy specialist discusses his paper in JAMA regarding the use of Johnson and Johnson’s Topamax to treat...
View ArticleDavid Wofsy, MD: Guidelines for industry funding of medical societies
Dr. Wofsy discusses the recent article in JAMA, which he co-authored, on the handling of industry payments to medical societies. A similar paper a few years ago caused significant changes in the way...
View ArticleBarbara Slade, MD: The CDC discusses Gardasil HPV vaccine safety
http://www.youtube.com/watch?v=2BDDq-LXmfM September 4 Produced and interviewed by Steven Greer, MD Dr. Barbara Slade of the CDC discusses her recent JAMA article on the safety and adverse event...
View ArticleChristoph Correll, MD: antipsychotics in children
Are Zyprexa, Risperdal, and Abilify overprescribed in children? Update: June 11, 2012 Since our extensive coverage of the marketing strategies that led to wide misuse of antipsychotics, JNJ agreed to...
View ArticleHemorrhagic Complications Associated With Aspirin
Best viewed in full screen mode July 23, 2012 By Steven Greer, MD An article in the June, 2012, JAMA reported the findings of a large meta-analysis of the use of daily aspirin for primary prevention of...
View ArticleViolent video games and aggressive behavior
March 30, 2014- Interviewed by Steven E. Greer, MD A recent JAMA paper connects the dots between violent video games and aggressive behavior. Author Craig Anderson, PhD, from Iowa State, reviews the...
View ArticlePhotodynamic therapy (PDT) to treat AK’s
September 2, 2014- Interviewed by Steven E. Greer, MD Gayatri Patel, MD MPH discusses her JAMA paper comparing the effectiveness of photodynamic therapy (PDT) versus liquid nitrogen cryotherapy to...
View ArticleDaily aspirin once again proves to be of no use and also deadly
November 17, 2014- By Steven E. Greer, MD A Japanese trial of daily aspirin for primary prevention of stroke and MI, published in JAMA, showed no statistically significant benefit in those outcomes....
View ArticleThe deadly risks of TAVR being downplayed to patients by hospitals
January 18, 2015- By Steven E. Greer, MD On July 20th, 2011, the FDA convened an advisory committee to help it determine whether to approve the first ever TAVR device called the Sapien, made by Edwards...
View Article
